These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8393913)

  • 1. The AP-1 binding site in the feline immunodeficiency virus long terminal repeat is not required for virus replication in feline T lymphocytes.
    Miyazawa T; Kohmoto M; Kawaguchi Y; Tomonaga K; Toyosaki T; Ikuta K; Adachi A; Mikami T
    J Gen Virol; 1993 Aug; 74 ( Pt 8)():1573-80. PubMed ID: 8393913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C/EBP site in the feline immunodeficiency virus (FIV) long terminal repeat (LTR) is necessary for its efficient replication and is also involved in the inhibition of FIV LTR-directed gene expression by pseudorabies virus ICP4.
    Kawaguchi Y; Tomonaga K; Maeda K; Ono M; Miyazawa T; Kohmoto M; Tohya Y; Mikami T
    Virology; 1995 Apr; 208(2):492-9. PubMed ID: 7747422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cis- and trans-regulation of feline immunodeficiency virus: identification of functional binding sites in the long terminal repeat.
    Thompson FJ; Elder J; Neil JC
    J Gen Virol; 1994 Mar; 75 ( Pt 3)():545-54. PubMed ID: 8126451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus.
    Sparger EE; Shacklett BL; Renshaw-Gegg L; Barry PA; Pedersen NC; Elder JH; Luciw PA
    Virology; 1992 Mar; 187(1):165-77. PubMed ID: 1310554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of insertion of multiple AP-1 binding sites into the U3 region of the long terminal repeat of feline immunodeficiency virus.
    Miyazawa T; Tomonaga K; Kawaguchi Y; Kohmoto M; Inoshima Y; Maeda K; Mikami T; Maedadel K [corrected to Maeda K]
    Arch Virol; 1994; 139(1-2):37-48. PubMed ID: 7529991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of feline immunodeficiency virus gene expression and replication by alphaherpesvirus ICP4 homologues.
    Kawaguchi Y; Maeda K; Miyazawa T; Ono M; Tsubota K; Tomonaga K; Mikami T
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2783-7. PubMed ID: 7931167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth properties of a feline immunodeficiency virus mutant which lacks an AP-1 binding site in primary peripheral blood mononuclear cells.
    Miyazawa T; Inoshima Y; Kohmoto M; Ikeda Y; Mikami T
    J Vet Med Sci; 1994 Oct; 56(5):869-72. PubMed ID: 7532437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequences within the feline immunodeficiency virus long terminal repeat that regulate gene expression and respond to activation by feline herpesvirus type 1.
    Kawaguchi Y; Norimine J; Miyazawa T; Kai C; Mikami T
    Virology; 1992 Sep; 190(1):465-8. PubMed ID: 1326814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of feline immunodeficiency virus long terminal repeat by feline herpesvirus type 1.
    Kawaguchi Y; Miyazawa T; Horimoto T; Itagaki S; Fukasawa M; Takahashi E; Mikami T
    Virology; 1991 Sep; 184(1):449-54. PubMed ID: 1651603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and in vitro characterization of attenuated feline immunodeficiency virus long terminal repeat mutant viruses.
    Bigornia L; Lockridge KM; Sparger EE
    J Virol; 2001 Jan; 75(2):1054-60. PubMed ID: 11134320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of feline immunodeficiency virus in feline and non-feline non-lymphoid cell lines by transfection of an infectious molecular clone.
    Miyazawa T; Kawaguchi Y; Kohmoto M; Sakuragi J; Adachi A; Fukasawa M; Mikami T
    J Gen Virol; 1992 Jun; 73 ( Pt 6)():1543-6. PubMed ID: 1318947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The feline herpesvirus type 1 ICP4 down-regulates feline immunodeficiency virus long terminal repeat (LTR)-directed gene expression via the C/EBP site in the LTR.
    Kawaguchi Y; Maeda K; Pecoraro MR; Inoshima Y; Jang HK; Kohmoto M; Iwatsuki K; Ikeda Y; Shimojima M; Tohya Y
    J Vet Med Sci; 1995 Dec; 57(6):1129-31. PubMed ID: 8720064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genome of feline immunodeficiency virus.
    Miyazawa T; Tomonaga K; Kawaguchi Y; Mikami T
    Arch Virol; 1994; 134(3-4):221-34. PubMed ID: 8129613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory properties of the integrated long terminal repeat of the feline immunodeficiency virus.
    Ikeda Y; Kawaguchi Y; Tomonaga K; Inoshima Y; Kohmoto M; Miyazawa T; Mikami T
    Virus Res; 1996 Apr; 41(2):201-7. PubMed ID: 8738180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of ORF2 on host cell tropism of feline immunodeficiency virus.
    Waters AK; De Parseval AP; Lerner DL; Neil JC; Thompson FJ; Elder JH
    Virology; 1996 Jan; 215(1):10-6. PubMed ID: 8553580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-binding properties of the putative AP-1 and ATF sequences in the feline immunodeficiency virus long terminal repeat.
    Ikeda Y; Inoshima Y; Kawaguchi Y; Maeda K; Kohmoto M; Kai C; Miyazawa T; Mikami T
    J Gen Virol; 1998 Jan; 79 ( Pt 1)():95-9. PubMed ID: 9460929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of treatment with chemical agents or infection with feline viruses on protein-binding properties of the feline immunodeficiency virus long terminal repeat.
    Ikeda Y; Kawaguchi Y; Inoshima Y; Kohmoto M; Shimojima M; Inada G; Sato E; Kai C; Miyazawa T; Mikami T
    Virus Res; 1997 Oct; 51(2):203-12. PubMed ID: 9498618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The feline immunodeficiency virus vif gene is required for productive infection of feline peripheral blood mononuclear cells and monocyte-derived macrophages.
    Lockridge KM; Himathongkham S; Sawai ET; Chienand M; Sparger EE
    Virology; 1999 Aug; 261(1):25-30. PubMed ID: 10441553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative activity of the feline immunodeficiency virus promoter in feline and primate cell lines.
    Mustafa F; Jayanth P; Phillip PS; Ghazawi A; Schmidt RD; Lew KA; Rizvi TA
    Microbes Infect; 2005 Feb; 7(2):233-9. PubMed ID: 15725384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in feline immunodeficiency virus host cell range correlate with envelope fusogenic properties.
    Pancino G; Castelot S; Sonigo P
    Virology; 1995 Feb; 206(2):796-806. PubMed ID: 7856093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.